See more : Whetron Electronics Co.,Ltd. (6722.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Liaoning Kelong Fine Chemical,Inc. (300405.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Liaoning Kelong Fine Chemical,Inc., a leading company in the Chemicals industry within the Basic Materials sector.
- Orient Telecoms Plc (ORNT.L) Income Statement Analysis – Financial Results
- Industrial & Prudential Investment Company Limited (INDPRUD.BO) Income Statement Analysis – Financial Results
- TOMONY Holdings, Inc. (8600.T) Income Statement Analysis – Financial Results
- Getchell Gold Corp. (GTCH.CN) Income Statement Analysis – Financial Results
- World Flex Public Company Limited (WFX.BK) Income Statement Analysis – Financial Results
Liaoning Kelong Fine Chemical,Inc. (300405.SZ)
About Liaoning Kelong Fine Chemical,Inc.
Liaoning Kelong Fine Chemical,Inc. manufactures and sells fine chemicals worldwide. The company offers polycarboxylate concrete admixture products, including polycarboxylate-based superplasticizers, slump retaining agents, and slump and water retaining admixtures, as well as polycarboxylate-based superplasticizers in powder forms; and polycarboxylate macro monomer products comprising polyether monomers, polyoxyethylene monoallyl ethers, and methoxy polyethylene glycol methacrylate. It also provides glycol ether products consisting of 2-phenoxyethanol and 1-phenoxy-2-propanol; and auxiliaries of textiles, such as hydrogen peroxide stabilizers, hydrophilic modifiers for amino silicon oils, and synthetic fiber hydrophilic finishing agents. In addition, the company offers polyethylene glycol monomethyl ether, hydrophilic polyester copolymer, castor oil ethoxylate, phosphate ester, polyoxyalkylene glycol/polyether, hydrophilic amino silicone oil, polyethylene glycol, sorbitan oleate and laurate, sorbitan stearate and trioleate, fatty alcohol and nonyl phenol ethoxylate, isotridecanol ethoxylate, and polyglycol glycidic ether condensation products; polyoxyethylene sorbitan monooleate, monolaurate, monostearate, and trioleate; and polyethylene glycol monooleate, monolaurate, and monostearate. Its polycarboxylate superplasticizers, cutting fluids, paint additives, and concrete admixtures are used in various areas, such as daily chemicals, pharmacy, textile printing, etc. The company was founded in 1988 and is based in Liaoyang, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 558.45M | 781.23M | 1.09B | 929.30M | 944.67M | 1.20B | 1.13B | 777.32M | 800.42M | 1.14B | 1.00B | 1.11B | 1.14B | 709.82M | 367.83M |
Cost of Revenue | 535.00M | 748.12M | 933.64M | 808.00M | 778.39M | 1.01B | 920.84M | 636.86M | 687.30M | 957.47M | 834.17M | 911.92M | 941.20M | 577.22M | 280.35M |
Gross Profit | 23.44M | 33.10M | 155.77M | 121.30M | 166.28M | 186.71M | 206.86M | 140.47M | 113.13M | 180.11M | 169.72M | 196.69M | 196.30M | 132.60M | 87.48M |
Gross Profit Ratio | 4.20% | 4.24% | 14.30% | 13.05% | 17.60% | 15.61% | 18.34% | 18.07% | 14.13% | 15.83% | 16.91% | 17.74% | 17.26% | 18.68% | 23.78% |
Research & Development | 9.60M | 13.09M | 10.59M | 22.01M | 13.36M | 12.49M | 25.50M | 9.54M | 10.37M | 8.47M | 11.59M | 18.67M | 19.87M | 0.00 | 0.00 |
General & Administrative | 13.09M | 13.42M | 12.87M | 19.40M | 12.30M | 14.66M | 14.53M | 8.29M | 8.49M | 8.05M | 5.63M | 4.76M | 5.97M | 27.72M | 12.51M |
Selling & Marketing | 15.43M | 23.95M | 27.75M | 39.95M | 61.35M | 66.60M | 67.51M | 44.55M | 46.38M | 46.82M | 41.00M | 42.09M | 46.49M | 29.31M | 17.70M |
SG&A | 90.78M | 37.37M | 40.63M | 59.35M | 73.65M | 81.26M | 82.04M | 52.84M | 54.86M | 54.87M | 46.63M | 46.85M | 52.46M | 57.03M | 30.21M |
Other Expenses | 28.00M | -990.84K | 383.15K | 10.97M | 44.51M | 83.90M | 13.65M | 4.20M | 5.14M | 6.95M | 4.37M | 468.77K | 1.54M | 46.78K | 15.27K |
Operating Expenses | 128.38M | 86.39M | 87.93M | 122.74M | 130.15M | 128.04M | 137.05M | 89.99M | 88.06M | 83.20M | 80.71M | 85.18M | 91.19M | 58.13M | 31.42M |
Cost & Expenses | 663.38M | 834.52M | 1.02B | 930.74M | 908.54M | 1.14B | 1.06B | 726.85M | 775.36M | 1.04B | 914.89M | 997.10M | 1.03B | 635.36M | 311.77M |
Interest Income | 2.95M | 2.03M | 2.38M | 2.60M | 1.95M | 1.78M | 1.22M | 661.52K | 804.25K | 485.94K | 252.95K | 575.29K | 645.82K | -0.55 | -0.40 |
Interest Expense | 27.29M | 27.72M | 31.82M | 34.21M | 35.84M | 40.03M | 30.64M | 30.01M | 38.26M | 41.85M | 25.45M | 29.13M | 25.74M | 10.67M | 7.40M |
Depreciation & Amortization | 43.92M | 48.17M | 45.08M | 46.17M | 44.80M | 40.18M | 35.43M | 26.72M | 24.69M | 23.36M | 16.14M | 14.90M | 12.89M | 13.86M | 7.42M |
EBITDA | -21.84M | -71.23M | 85.00M | 6.89M | 88.91M | -23.42M | 94.54M | 76.35M | 30.37M | 112.31M | 103.88M | 121.07M | 112.37M | 74.47M | 56.06M |
EBITDA Ratio | -3.91% | 1.98% | 10.15% | 5.18% | 13.34% | 15.62% | 10.37% | 10.82% | 7.25% | 11.21% | 10.93% | 11.48% | 10.49% | 10.72% | 15.24% |
Operating Income | -105.18M | -151.09M | 7.66M | -86.09M | -38.09M | -188.86M | 14.81M | 15.42M | -38.13M | 40.15M | 57.92M | 76.48M | 75.12M | 62.20M | 48.65M |
Operating Income Ratio | -18.84% | -19.34% | 0.70% | -9.26% | -4.03% | -15.79% | 1.31% | 1.98% | -4.76% | 3.53% | 5.77% | 6.90% | 6.60% | 8.76% | 13.23% |
Total Other Income/Expenses | 11.01M | -990.84K | 383.15K | 10.97M | 44.51M | 83.90M | 13.65M | -23.08M | 5.12M | 6.95M | 4.37M | -28.25M | -24.38M | 46.78K | 15.27K |
Income Before Tax | -94.17M | -152.08M | 8.04M | -75.12M | 6.42M | -104.97M | 28.47M | 19.62M | -33.00M | 47.10M | 62.29M | 76.94M | 76.66M | 62.25M | 48.67M |
Income Before Tax Ratio | -16.86% | -19.47% | 0.74% | -8.08% | 0.68% | -8.78% | 2.52% | 2.52% | -4.12% | 4.14% | 6.21% | 6.94% | 6.74% | 8.77% | 13.23% |
Income Tax Expense | 6.13M | -33.35M | -7.37M | -13.52M | -3.15M | -3.38M | 5.86M | 3.91M | -4.30M | 8.92M | 9.62M | 12.07M | 12.36M | 9.82M | 13.74M |
Net Income | -100.23M | -118.75M | 11.92M | -60.74M | 10.78M | -100.49M | 22.81M | 15.73M | -28.69M | 38.20M | 52.70M | 64.88M | 64.30M | 52.43M | 34.93M |
Net Income Ratio | -17.95% | -15.20% | 1.09% | -6.54% | 1.14% | -8.40% | 2.02% | 2.02% | -3.58% | 3.36% | 5.25% | 5.85% | 5.65% | 7.39% | 9.50% |
EPS | -0.35 | -0.41 | 0.04 | -0.21 | 0.04 | -0.51 | 0.09 | 0.08 | -0.11 | 0.19 | 0.27 | 0.33 | 0.33 | 0.28 | 0.80 |
EPS Diluted | -0.35 | -0.41 | 0.04 | -0.21 | 0.04 | -0.51 | 0.09 | 0.08 | -0.11 | 0.19 | 0.27 | 0.33 | 0.33 | 0.28 | 0.80 |
Weighted Avg Shares Out | 288.02M | 289.21M | 289.21M | 289.21M | 294.92M | 197.94M | 247.69M | 198.12M | 258.57M | 204.70M | 193.92M | 193.93M | 193.93M | 188.09M | 43.69M |
Weighted Avg Shares Out (Dil) | 288.02M | 289.21M | 289.21M | 289.21M | 294.92M | 197.94M | 247.69M | 198.12M | 258.59M | 204.70M | 193.92M | 193.93M | 193.93M | 188.09M | 43.69M |
Source: https://incomestatements.info
Category: Stock Reports